Edgen Stock·Sep 18 2025, 10:51戻る
戻る
Novo Nordisk Secures EU Approval for Rybelsus Cardiovascular Benefit Label
Edgen Stock·Sep 18 2025, 10:51
[1] Will Rybelsus' Updated EU Label Propel Fresh Growth Potential for NVO?[2] Novo Nordisk stock rises after EU approves heart benefit label for Rybelsus - Investing.com[3] Novo Nordisk (CPSE:NOVO B) Is Up 5.2% After Rybelsus Wins EU Cardiovascular Label Update – Has The Bull Case Changed? - Simply Wall St